Document:

EXHIBIT 10.03

 

 

Contribution Agreement

 

 

This Contribution
Agreement (the “Agreement”), effective as of January 2, 2016, by and between Elizabeth Rosellini, an individual
(“Transferor”) and Nexeon MedSystems Inc, a Nevada corporation (“Transferee”).

 

WHEREAS, Transferor owns
shares of Restricted Common Stock of Telemend Medical Inc, and shares of Restricted Common Stock of Nuvinat Medical Inc. and wishes
to contribute said Shares to Transferee. Transferee whishes to acquire said Shares from Transferor.

 

WHEREAS, Transferor and
Transferee desire to enter into this Agreement pursuant to which Transferor will transfer the Shares to Transferee in exchange
for One Million Eight Hundred Thousand (1,800,000) shares of Restricted Common Stock of Transferee.

 

NOW, THEREFORE,
in consideration of the mutual covenants, terms and conditions set forth herein, and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

 

1.       Contribution of Assets. On the terms and subject to the conditions set forth in this Agreement, Transferor owns Two
Hundred Fourteen (214) shares of Restricted Common Stock of Telemend Medical Inc, a Delaware corporation, and Sixty Thousand (60,000)
shares of Restricted Common Stock of Nuvinat Medical Inc, a Nevada corporation (collectively the “Shares”) and upon
the terms and subject to the conditions set forth in this Agreement Transferor hereby transfers all of her right, title, and interest,
free and clear of any and all liens or encumbrances, in and to the Transferee.

 

2.       Consideration. As consideration for the contribution of the Shares by Transferor to Transferee, Transferor will receive
One Million Eight Hundred Thousand (1,800,000) shares of Transferee’s Restricted Common Stock.

 

3.       Representations and Warranties of the Transferors. Transferor represents and warrants to Transferee that:

 

(a)       Authority. Transferor has all requisite personal power, authority and capacity to execute and deliver this Agreement,
to carry out her obligations hereunder, and to consummate the transactions contemplated hereby. Transferor has obtained all necessary
approvals for the execution and delivery of this Agreement, the performance of her obligations hereunder, and the consummation
of the transactions contemplated hereby. This Agreement has been duly executed and delivered by Transferor and (assuming due authorization,
execution and delivery by Transferee) shall constitute Transferor’s legal, valid and binding obligation, enforceable against
her in accordance with its terms.

 

4.       Representations and Warranties of the Transferee. Transferee represents and warrants to Transferor that:

 

(a)       Organization of Transferee. Transferee is corporation duly organized, validly existing, and in good standing under
the laws of the State of Nevada.

 

(b)       Authority. Transferee has all requisite corporate power and authority to execute and deliver this Agreement, to carry
out its obligations hereunder, and to consummate the transactions contemplated hereby. Transferee has obtained all necessary company
approvals for the execution and delivery of this Agreement, the performance of its obligations hereunder, and the consummation
of the transactions contemplated hereby. This Agreement has been duly executed and delivered by Transferee and (assuming due authorization,
execution and delivery by Transferor) shall constitute Transferee’s legal, valid and binding obligation, enforceable against
it in accordance with its terms.

 

    	1

    	 

    

 

5.       Further Assurances. Transferor and Transferee agree to execute any and all documents and instruments of transfer,
assignment, assumption or novation and to perform such other acts as may be reasonably necessary or expedient to further the purposes
of this Agreement and the transactions contemplated by this Agreement.

 

6.       Entire Agreement. This Agreement constitutes the sole and entire agreement of the parties to this Agreement with
respect to the subject matter contained herein, and supersedes all prior and contemporaneous understandings, representations and
warranties and agreements, both written and oral, with respect to such subject matter.

 

7.       Successors and Assigns. This Agreement shall be binding upon and shall inure to the benefit of the parties hereto
and their respective successors and permitted assigns.

 

8.       No Third-Party Beneficiaries. This Agreement is for the sole benefit of the parties hereto and their respective successors
and permitted assigns and nothing herein, express or implied, is intended to or shall confer upon any other person any legal or
equitable right, benefit or remedy of any nature whatsoever, under or by reason of this Agreement.

 

9.       Headings.
The headings in this Agreement are for reference only and shall not affect the interpretation of this Agreement.

 

10.     Amendment and Modification; Waiver. This Agreement may only be amended, modified or supplemented by an agreement
in writing signed by each party hereto. No waiver by any party of any of the provisions hereof shall be effective unless explicitly
set forth in writing and signed by the party so waiving. Except as otherwise set forth in this Agreement, no failure to exercise,
or delay in exercising, any rights, remedy, power or privilege arising from this Agreement shall operate or be construed as a waiver
thereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further
exercise thereof or the exercise of any other right, remedy, power or privilege.

 

11.     Governing Law. This Agreement shall be governed by and construed in accordance with the internal laws of the State
of Texas without giving effect to any choice or conflict of law provision or rule (whether of the State of Texas or any other jurisdiction)
that would cause the application of Laws of any jurisdiction other than those of the State of Texas.

 

12.     Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all
of which together shall be deemed to be one and the same agreement. A signed copy of this Agreement delivered by facsimile, e-mail
or other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original signed copy
of this Agreement.

 

[SIGNATURE PAGE FOLLOWS]

 

    	2

    	 

    

 

IN WITNESS
WHEREOF, the parties hereto have executed this Contribution Agreement to be effective as of the date first above written.

 

	Nexeon MedSystems Inc	 	
	 	 	 	 
	 	 	 	 
	By:	/s/
    Ron Conquest	 	
	 	Ron Conquest, COO	 	

 

 

		 	
	 	 	 	 
	 	 	 	 
	By:	/s/
    Elizabeth Rosellini	 	
	 	Elizabeth Rosellini, Individually	 	

 

 

    	3EXHIBIT 10.04

 

 

EXECUTIVE SERVICES AGREEMENT

 

THIS
AGREEMENT, made as of January 1, 2016 by and between Ronald Conquest, an individual, (the
“Executive”) and Nexeon MedSystems Inc, a Nevada corporation, (the “Company”).

 

WHEREAS, the Company wishes to retain
the services of Ronald Conquest as its Director and Chief Operating Officer;

 

NOW THEREFORE, In consideration of the
mutual covenants set forth in this Agreement and for other good and valuable consideration, the receipt and sufficiency of which
is hereby acknowledged, the Company and the Executive hereby agree to the following:

 

1.          ENGAGEMENT.
The Company hereby retains the executive management services of the Executive as a Director and its Chief Operating Officer (COO)
on a full time basis. Executive shall report to the Chief Executive Officer of the Company and his duties shall include managing
all aspects of the day-to-day operations of the Company’s business. Executive’s services will commence on the date
set forth herein above or such other date as the parties may mutually agree (the “Commencement Date”).

 

2.        
DUTIES.

 

2.1     Position.
Executive as Chief Operating Officer shall be in charge of faithfully and diligently running the Company’s operations.

 

2.2     Reasonable
Efforts. Executive will provide his reasonable efforts on behalf of the Company, and will abide by all policies made by the
Manager and the Company’s Board of Directors, if any, as well as all applicable federal, state, and local laws and regulations.
Executive shall act in the best interest of the Company at all times. Executive shall be obligated to devote Executive's full
business time and efforts to the performance of Executive's assigned duties for Company and shall spend no less than ninety five
percent (95%) of his professional time pursing the interests of the Company. Executive may serve as a director, manager and owner
of other enterprises or engage in such other charitable, civil, and similar pursuits, none of which shall compete at any time
with any of the Company’s interests.

 

2.3     Services.
Executive's responsibilities shall include but not be limited to the following:

 

Managing all aspects
of the day to day operations of the Company;

 

Obtaining any managing
the compliance of all necessary regulatory approvals;

 

Managing the Legal
and Accounting functions of the Company;

 

Sourcing funds through
financings, grants, or matching funds; and

 

Development of strategic
relationships.

 

    	1

    	 

    

 

2.4     Work
Location. Executive's principal place of work shall be located in Lexington, Kentucky or such other location as the parties
may mutually agree upon from time to time. The Company has no objection if the Executive chooses to work from his home.

 

3.         
COMPENSATION AND BENEFITS.

 

3.1     Salary.
Executive will be paid a salary (“Salary”) in the amount of $100,000 beginning January 1, 2016 and
ending September 30, 2016. Executive’s salary for the year beginning October 1, 2016 and ending September 30, 2017
shall be $138,000 per year. Executive’s salary for the year beginning October 1, 2017 and for each succeeding year
shall be $174,000 per year. Such salary amounts shall be payable in equal bi-weekly increments on the 15th and
last day of each month. At the discretion of Executive Company shall enter into a consulting agreement with an entity
designated by Executive to provide the services of Executive on the same terms and conditions as provided for
herein.

 

3.2     Benefits.
Executive will receive four (4) weeks paid vacation every twelve (12) months, subject to the Company’s policies adopted
from time-to-time relating to accrual and scheduling of vacations. If the Executive requests more than four (4) weeks’ vacation
every twelve (12) months, any and all vacation beyond four (4) weeks shall be without compensation. In addition Executive shall
receive additional compensation for the cost of Executive and his spouse Medicare and Medicare Supplement Health Insurance. If
Executive’s employment is terminated for any reason other than for Cause for six (6) months after termination, Company will
pay compensation for health coverage.

 

The foregoing Executive
compensation is subject to such raises, bonuses, incentives, or additional benefits and/or plans as the Company, in its discretion,
may grant Executive from time-to-time or are made available to other Executive s of the Company

 

3.3     Expenses.
The Executive shall be reimbursed for documented travel and lodging expenses and any other out of pocket Company related expenses
in the normal course of business. Company shall provide Executive with a Credit or Debit Card to be used exclusively for expenses
directly related to the operation of the Company. In the event the Company does not provide a Credit or Debit care then the Company
shall advance the sum of $3000 to Executive for use in conjunction with Company expenses and Executive shall submit, from time
to time, expense reports and receipts for such expenses and the Company shall advance further sums to Executive for the difference
between the submitted expense report and the sum of $3000. Upon the expiration or termination of this Agreement any amount of
the $3000 not accounted for by an expense report shall be subtracted from any final amount due Executive from the Company.

 

3.4     Annual
Bonus. Executive shall be entitled to receive a yearly annual bonus. The amount of such bonus shall be based upon criteria
established by the Compensation Committee of the Board of Directors. Provided, however, such bonus shall not exceed twenty percent
(20%) of Executive’s annual base salary in effect for the period for which the bonus is granted. During the term of this
Agreement, the yearly annual bonus shall be paid within thirty (30) days of the anniversary date of this agreement.

 

    	2

    	 

    

 

3.5     
Stock Award. Upon inception of the Company at 12/07/2015 the Company shall issue to Executive 500,000 shares of the Company’s
Common Stock in the amount of 500,000 shares of the Company’s Common Stock (the “Shares”). 212,000 of the Shares
shall Vest as of the date hereof and the remaining 288,000 shares shall Vest at the rate of 8,000 shares per month for thirty
six (36) months.

 

3.6     Forfeiture
of Stock Not Vested. The stock certificate evidencing the Shares shall be registered on the Company's books in the name of
the Executive and delivered to him. The Company reserves the right to place a legend on the Shares restricting the transferability
of such shares pursuant to SEC Rule 144. Even though some of the Shares may not yet be vested, the Executive shall be entitled
to all rights of a stockholder of the Company, including the right to vote and receive dividends with respect to such Shares.
Any Shares not Vested at the end of the Term, or pursuant to Section 4 hereof, shall be deemed forfeited and shall be deemed transferred
to the Company. Any Shares, which are not yet be vested, are not transferable by the Executive by means of sale, assignment, exchange,
pledge, or otherwise. Vested shares shall nevertheless continue to be subject to any restriction imposed under applicable securities
laws.

 

4.         
TERM AND TERMINATION

 

4.1     Term.
The term of this Agreement is four (4) years from the “Commencement Date” (the “Term”) and this Agreement
shall automatically renew for additional one year periods unless a termination notice is provided in writing to the other party
90 days prior to the expiration of the Term. The Term may however be terminated earlier as set forth in section 4.2 below.

 

4.2     Termination.

 

(a)     Without
Cause. If the Company terminates Executive ’s employment during the Term hereof without Cause, then the Company will
be responsible to pay Executive ’s then existing Salary and benefits for a period equal to fifty percent (50%) of the remaining
Term of this Agreement. 

 

(b)     With
Cause. If the Company terminates Executive ’s employment for Cause at any time, the Company’s sole responsibility
shall be to pay Executive ’s then existing Salary, benefits, and expenses through the date of termination.

 

(c)     Cause.
As used in this Agreement, “Cause” for the Company to terminate this Agreement shall mean: (1) Executive ’s
conviction of, or plea of guilty or nolo contendere, to a felony or any crime involving moral turpitude; (2) an act of personal
dishonesty by Executive in connection with his responsibilities as an executive of the Company; (3) an act by Executive that constitutes
willful misconduct or material negligence in the performance of his duties that is not rectified within 30 days following written
notification by the Company; (4) Executive ’s repeated and unexplained or unjustified absence from performing his duties
for the Company.

 

    	3

    	 

    

 

(d)     Termination
upon Death or Disability.
Executive's employment shall be terminated upon the death
of the Executive. In the event of the Disability (as hereinafter
defined) of the Executive during his employment, the Company
shall have the right to terminate the employment of Executive
upon giving Ninety (90) days advance
written notice to that effect to the Executive, provided that the Executive
shall not have returned to active service with the Company
prior to the end of such Ninety (90) day notice
period. For purposes of this Agreement, the term "Disability"
shall mean any physical or mental disability or incapacity
that can be reasonably diagnosed by a licensed physician to result in
death or that will render the Executive incapable
of performing the essential functions required of the
Executive in accordance with the obligations
set forth in Section 2 hereof for a period of
six (6) consecutive months or for shorter periods aggregating to
nine (9) months during any consecutive twelve (12)
month period. If Executive is terminated as a result of Disability Executive will receive
or in the event of death, Executive's
estate or heirs will receive, a severance payment equivalent
to one year’s Salary and benefit in effect at the time of death, less federal
and state income and employment taxes.

 

(e)     Termination
for Good Reason. The Executive, upon ninety (90) days’ prior written notice given to the Company, shall have the right
at any time to terminate the Executive’s employment with the Company for Good Reason. “Good Reason” shall mean
(i) the occurrence, without the Executive’s express written consent, of a material reduction in the level of the Executives
compensation or material reduction in Executive’s duties and responsibilities, unless such reduction applies to all similarly
situated employees; (ii) a demand, without the Executive’s express written consent, that the Executive relocate to an office
of the Company more than fifty (50) miles from the office in which the Executive was previously employed; or (iii) the Company’s
uncured breach of a material term of this Agreement. In the event the Executive’s employment is terminated for Good Reason,
Executive will receive a severance payment equivalent to six (6) months of Base Salary and benefits, less federal and state income
and employment taxes. 

 

(f)     Change
in Control. If the Company terminates Executive’s employment during the Term hereof as a result of a Change in Control,
then the Company will be responsible to pay Executive ’s then existing Salary and benefits for the remaining Term of this
Agreement. 

 

(g)     As
used in this Agreement, a "Change in Control" of the Company shall mean the occurrence of any of the following: i) any
person, group or organization, other than the Executive, is or becomes the beneficial owner, directly or indirectly, of securities
or membership interests of the Company representing fifty percent (50%) or more of the combined voting power of the Company's
outstanding securities or membership interests then having the right to vote for the election of the Company Manager or a Board
of Director of the Company; or ii) the individuals who at the Effective Date of this Agreement constitutes the Manager of the
Company or Board of Directors, if any, of the Company cease for any reason to constitute a majority thereof unless the election,
or nomination for election, of each new director was approved by the Executive; or iii) the business or over fifty percent (50%)
of the business revenues of the Company for which the Executive's services are principally performed is or are sold or otherwise
disposed of by the Company (including a subsidiary of the Company).

 

    	4

    	 

    

 

(h)     Conditions
to Receive Severance. As a
condition to receiving any severance, Executive agrees to
execute a full general release satisfactory to the Company,
releasing all claims, known or
unknown that Executive may
have against Company arising out of or in any way
related to Executive's employment or termination of employment
with Company prior to receipt of the severance package.

 

(i)     Opportunity
to Cure.
Notwithstanding the foregoing,
it shall be
a condition precedent to the
Company's
right to terminate
the Executive's
employment for Cause and the Executive's
right to terminate
that (i) the
party seeking the
termination shall first
have given the
other party written
notice stating with
specificity the reason
for the termination
("breach")
and (ii) if
such breach is susceptible
of cure or remedy, a
period of thirty (30) days from and after
the giving of such written notice shall
have elapsed without
the breaching party having substantially
cured or remedied such breach during such
thirty (30) day period, unless such
breach cannot be
cured or remedied
within thirty (30) days,
in which case
the period for remedy or cure
shall be extended
for a reasonable time (not
to exceed an additional thirty (30) days) provided the breaching party has
made and continues to
make a diligent effort
to effect such remedy
or cure. 

 

5.         
DISCLOSURE OF INFORMATION, ASSIGNMENT OF INTELLECTUAL PROPERTY, AND RESTRICTIVE COVENANT:

 

5.1     Executive
acknowledges that the Company is in the business of developing, producing, and selling advanced medical technologies from which
the Company has developed a reputation. extensive "know-how", and trade secrets relating to its business and its customers,
some of which Executive will obtain the knowledge of while employed by the Company; which the Company has spent substantial amounts
of effort and money to accumulate this know-how and trade secrets and develop its reputation and its relationship with its present
and future clients. 

 

5.2     Confidential
Information. Executive recognizes and acknowledges
that the Company’s Confidential Information includes information or trade secrets relating to the properties, composition
or structure of the Company’s products or proposed products or the development, formulation or processing thereof or hardware,
information technology and software therefore or the Company’s business, including, without limitation, any and all patents,
patents-pending, patent applications, copyrights, trademarks, service marks, patentable processes and/or products in development,
or any other intellectual property, all trade secrets and proprietary information concerning the Company’s business and
affairs, product specifications, data, know-how, formulae, compositions, processes, designs, sketches, photographs, graphs, drawings,
samples, inventions and ideas, past, current and planned research and development, customer or supplier lists, current and anticipated
customer requirements, price lists, market studies, business plans, computer software and programs and database technologies,
systems, structures and architectures and related processes, formulae, compositions, improvements, devices, know-how, discoveries,
concepts, ideas, designs, method, algorithms, names and expertise of Executive s and consultants, inventions (whether patentable
or not), schematics and other technical, business, financial, customer and product development plans, forecasts, strategies and
information, whether or not marked “confidential. Additionally, Executive recognize that in the course of Executive ’s
duties, Executive will have access to similar information of the Company’s customers, suppliers or other entities which
the Company is required by contract or professional business practices to keep confidential, and which shall also be deemed as
Confidential Information and which Executive agrees to treat as such. Executive will not, during or after the term of this Agreement,
in whole or in part, disclose any Confidential Information to any person, firm corporation, association or other entity for any
reason or purpose whatsoever, nor shall Executive make use of such information and property for his own purposes or for the benefit
of any other person, firm, corporation, association or any other entity (except for the Company) under any circumstances during
or after the term of this agreement.

 

    	5

    	 

    

 

5.3     Assignment
of Intellectual Property.
Executive agrees to assign and hereby assigns to the Company (the “Assignment”)
any and all rights, improvements, and copyrightable or patentable subject matter and other intellectual property relating to the
Company business, which Executive conceives or develops, either alone or with others, or which otherwise arise during the term
of Executive’s employment with the Company and for a period of six (6) months thereafter (“Assignable Property”).
Executive agrees not to assert any rights against the Company or seek compensation from the Company for the foregoing assignment
or the Company’s use of Assignable Technology. Executive will promptly disclose to the Company all knowledge that Executive
obtains regarding Assignable Property, and at the request of the Company, and without expense or additional compensation, Executive
will provide the Company with whatever assistance, including (i) signing whatever documents as are requested by the Company to
further evidence and perfect the Assignment and obtain for the Company patents, copyright protection, assignment of rights and
protection of trade secrets, or (ii) taking any other action the Company deems appropriate for securing or protecting its rights
in Assignable Property or other intellectual property of the Company.

 

5.4     Company
Property. Executive
recognizes that all materials that are or which may come into Executive's possession during Executive's employment with the Company
relating to the nature, operation, or activities of the Company remain the Company's property. Such materials may consist of agreements,
invoices, memoranda, books, forms, reference materials, computer programs, trade secrets, copyrights, trademarks, specifications,
designs, programming, promotional material, advertising material, selling material, financial material, address books, lists,
rolodexes, notes, information pertaining to negotiations, pricing procedures, technical data and the like unless such property
belongs to Executive prior to his employment. The Company is aware that the Executive has books, documents, and other items acquired
prior to his employment that he will use in his day to day work. All such materials are the Company's property and Executive will
not copy or make extracts of any such materials and will promptly return all such materials to the Company upon demand or, regardless
of whether such demand is made, after the termination of Executive’s employment with the Company.

 

    	6

    	 

    

 

5.5     Limited
Non-Competition. For the period the
Executive is paid and for two (2) years after the Executive leaves the employment of the Company and or ceases to be an Officer
and Director of the Company, Executive shall not become, directly or indirectly, an Executive of, or provide consulting services
for, or have any ownership interest in, any other business entity that manufactures or sells “Competitive Products”.
As used herein, “Competitive Products” means: any medical technology or devices, which the Company develops or acquires
the right sell from time to time during the term of this Agreement.

 

5.6     Executive
acknowledges that the foregoing provision’s restrictions and time limitations are reasonable and properly required for the
adequate protection of the business of the Company and that in the event such restriction or limitation is deemed to be unreasonable
by an arbitration panel, then the Executive and the Company agrees to submit to the reduction of said restriction and limitation
to such as the Court may deem reasonable.

 

5.7     It
is the desire and intent of the parties that the provisions of this paragraph shall be enforced to the fullest extent possible
under the laws and public policies applied in each jurisdiction which enforcement is sought. Accordingly, if any particular provision
of this Agreement or portion of this paragraph shall be adjudicated to be invalid or unenforceable, then the subject provision
or paragraph shall be deemed amended or deleted there from, and the provision or paragraph adjudicated to be invalid and unenforceable
shall be deemed revised in accordance with any such jurisdiction. Such deletion or revision, however, applies only with respect
to the operation of this Agreement in the particular jurisdiction in which such adjudication is made.

 

5.8     In
the event of a breach of, or threatened breach by the Executive of, of the provisions of §5, the Company shall be entitled
to an injunction restraining the Executive from violating these covenants. Nothing herein shall be construed as prohibiting the
Company from pursuing any and all other remedies available to it for such breach or threatened breach including recovery of damages
from the Executive, which such damages shall be paid promptly, excluding the cost of collection thereof.

 

6.         
GENERAL

 

6.1     Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the Executive and the Executive's, heirs, executors,
administrators, estate, beneficiaries, and legal representatives. Neither party may assign this Agreement without the consent
of the other party. The rights and obligations of the Company under this Agreement shall inure to the benefit of and shall be
binding upon the successors and assigns of Company.

 

6.2     Waiver.
Either party's failure to enforce any provision of this Agreement shall not in any way be construed as a waiver of any such
provision, or prevent that party thereafter from enforcing each and every other provision of this Agreement.

 

    	7

    	 

    

 

6.3     Attorneys'
Fees. Each side will bear its own attorneys' fees in any dispute unless a statutory section at issue, if any, authorizes the
award of attorneys' fees to the prevailing party.

 

6.4     Governing
Law. This Agreement will be governed by and construed in accordance with the laws of the United States and the State of Kentucky.

 

6.5     Notices.
Any notice required or permitted by this Agreement shall be in writing and shall be delivered as follows with notice
deemed given as indicated: (a) by personal delivery when delivered personally; (b) by overnight courier upon written
verification of receipt; (c) by telecopy or facsimile transmission upon acknowledgment of receipt of electronic transmission;
or (d) by certified or registered mail, return receipt requested, upon verification of receipt. Notice to the company shall
be sent to the attention of the Company's Manager and Board of Directors, if any.

 

6.6     Counterparts.
The parties hereto agree that this Agreement may be executed in identical counterparts. This Agreement will be binding
and enforceable on all parties even though signed in counterparts.

 

6.7     Entire
Agreement. This Agreement constitutes the entire understanding between executive and the Company relating to Executive's employment.
This agreement supersedes and replaces any prior verbal or written agreements between the Company and Executive. This Agreement
may not be modified or amended except by a written agreement signed by both Executive and the Manager of the Company. No oral
waiver, amendment or modification will be effective under any circumstances whatsoever.

 

6.8     Non-Solicitation
of Executives. Executive agrees that for a period of two (2) years after termination, Executive shall not recruit, attempt
to recruit, or directly or indirectly participate in the recruitment of any Company Executive, provided however, any general public
recruitment responded to by Company Executive s will not be a breach this Agreement.

 

6.9     Non-Solicitation
of Customers or Prospects. Executive agrees that during the term of this Agreement and for a period of one (1) year after
the termination of his employment, Executive will not, either directly or indirectly solicit, separately or in association with
others, attempt to solicit, canvass or interfere with any current or former customer, prospect or supplier of the Company in a
manner that directly competes with the Business.

 

6.10     Additional
Representations of Executive. Executive represents and warrants to the Company that Executive is not party to any written
or oral agreement with any third party that would restrict Executive's ability to enter into the Confidentiality and Proprietary
Information Agreement or to perform Executive’s obligations hereunder and that Executive will not, by joining the Company,
breach any non-disclosure, proprietary rights, non-competition, no solicitation or other covenant in favor of any third party.

 

    	8

    	 

    

 

6.11     Indemnity.
The Company agrees to indemnify, defend, and hold harmless the Executive to the fullest extent permitted by law for any and
all acts or non-action Executive may have committed during the period during which he was an officer, director and/or
Executive of the Company or any subsidiary thereof, or of any other entity of which he served as an officer, director or
Executive at the request of the Company. The indemnity shall include any and all claims, liability, costs, and expenses,
including any and all costs of litigation and defense, including attorney’s fees, arising from or in connection with
any and all claims and causes of actions for liabilities, damages, losses, expenses or proceeding against the Executive to
which Executive may be made a party by reason of being an officer, director, or Executive of the Company, any subsidiary or
affiliate, or any other corporation the Executive serves as an officer, director, or Executive at the Company’s
request. In addition the Company agrees to obtain a directors and officers liability insurance policy covering the executive
and to continue and maintain such policy. The amount of coverage shall be reasonable in relation to the Executive's position
and responsibilities during the term of employment but in no event shall the amount of coverage be less than three million
dollars ($3,000,000) in the aggregate provided that the cost and availability of such insurance is reasonable within the
marketplace. The Company hereby agrees that this obligation of indemnification survives the expiration or termination of this
Agreement.

 

In Witness whereof the parties
hereto have signed or caused to be signed this Agreement as of the dated first set forth above.

 

	Ronald
                                         Conquest (“Executive ”)
	 	
	 	 	 	 
	 	 	 	 
	By:	/s/
    Ronald Conquest	 	
	 	Ronald Conquest , Individually	 	

 

 

	Nexeon MedSystems Inc (“Employer”)	 	 
	 	 	 	 
	 	 	 	 
	By:	/s/
    William M. Rosellini	 	
	 	William M. Rosellini, CEO	 	

 

 

 

    	9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00259-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00259-of-00352.parquet"}]]